SAFE Fertility Group PCL Joins The 2nd China International Reproductive Medicine and Health Conference in Chengdu, Showcasing PGTSEQ Technology as a Leader in Assisted Reproductive Medicine
Chengdu, People’s Republic of China – April 12, 2025 – SAFE Fertility Group PCL participated in The 2nd China International Reproductive Medicine and Health Conference, where Dr. Wiwat Quangkananurug, Chief Executive Officer of the company, was invited as a distinguished international speaker. He presented on the topic “PGTSEQ GIVE HIGHER SUCCESS than NGS”, which attracted significant attention from both Chinese and international attendees.
This participation marked another milestone for SAFE Fertility Group PCL in demonstrating its technological leadership in the field of reproductive medicine. The focus was on PGTSEQ, an advanced embryo genetic screening technology that enhances pregnancy success rates compared to conventional NGS systems, gaining the interest of experts and participants from around the world.
In addition, medical professionals and fertility specialists from SAFE Fertility Group PCL provided personalized consultations to Chinese individuals seeking fertility treatment during the event, which took place from April 12-13, 2025. Throughout the conference, many attendees visited the booth
SAFE Fertility Group PCL’s involvement in this international event reflects its ongoing commitment to expanding access to high-quality reproductive healthcare services in global markets. It also reinforces Thailand’s positioning as a leading international destination for advanced fertility treatment.